Wang Xiaoying, M.S. Med

Department:Gastroenterology

Medical School:Zhejiang University School of Medicine, China

Academic Rank:Associate Chief Physician


Appointment

Clinical / Research Interests

Mucosal disorders of the stomach, small intestine and colon, especially inflammatory bowel disease (ulcerative colitis and Crohn's disease) diagnosis and therapy

Professional Highlights

Professional Appointments

Education Experience

Research Summary

Linc-CAD/ANKRD22 promotes by regulating mitochondrial Ca2+ load on the molecular mechanism of macrophage activation

NKRD22/PHLPP promotes ROS production, causing intestinal mucosal barrier damage in inflammatory bowel disease on the molecular mechanism


Publications

Dingting Xu#, Hanyun Zhang#, Xiaoying Wang*. Effects of tin caulis dendrobium polysaccharide on the prevention of non-alcoholic fatty liver disease in rats, Revista Brasileira De Zootecnia-Brazilian Journal of Animal Science. 2017; 46(8): 652-656.

Wang XY#, Chen Y, Du Q. Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia. EUR Rev Med Pharmacol Sci 2013;17:1114-1116.

Wang XY#, Chen ZH, Zhang RY, et al. Construction of a eukaryotic expression vector Pegfp-c1-bmp-2 and its effect on cell migration. 2012;13(5):356-363.


Current Program

ANKRD22/PHLPP promotes Akt mitochondrial translocation and ROS production, causing intestinal mucosal barrier damage in inflammatory bowel disease study on the molecular mechanism of injury. Funding Source: National Natural Science Foundation of China.

Find People

Search by Family Name

Find A Department

Search by Departments